About CDH1

The CDH1 gene (Cadherin 1) on chromosome 16q22 Germline mutations in CDH1 cause hereditary diffuse gastric cancer (HDGC) with ~70% lifetime risk, and lobular breast cancer. Key targets include Exons 1–16 for comprehensive mutation screening.

Mutations: Truncating, missense, promoter hypermethylation | GC content: 52% | Target exons: Exons 1–16

CDH1 Primer Design Challenges

  • Promoter CpG methylation: Epigenetic silencing via promoter hypermethylation is a key inactivation mechanism requiring bisulfite-based primer design
  • Large gene structure: 16 exons spanning ~100 kb with large introns (intron 1 = 27 kb) complicate genomic amplification
  • Multiple mutation types: Missense, frameshift, splice-site, and large deletions require comprehensive primer coverage

Recommended Primer Design Parameters for CDH1

ParameterStandard ExonsOptimized Regions
Primer length20–22 nt22–25 nt
GC content45–55%50–60%
Tm58–62°C60–65°C
Amplicon size150–300 bp180–350 bp
Annealing temp58–60°C60–64°C (touchdown)
PCR additiveStandardOptional 3–5% DMSO for problematic regions

Recommended Primer Sequences for CDH1

Target RegionForward Primer (5′→3′)Reverse Primer (5′→3′)Amplicon
Exon 7 (extracellular)5′-GAGGTGCTGTTGCCAGTCAT-3′5′-CATCAGCAAGAGCATGAGCA-3′168 bp
Exon 12 (cytoplasmic)5′-GCTCACAGTGTGTGACTGGA-3′5′-ACCTTGAGAGGTGACGCTTG-3′213 bp

Key SNPs to Avoid in Primer Binding Sites

When designing CDH1 primers, avoid these clinically significant variants:

  • rs121964898 (R732Q) — Exon 12 missense variant in HDGC
  • rs121964878 (1003C>T) — Premature stop in exon 7

Clinical Validation Required
All CDH1 primers designed with VigyanLLM are for research use only. Clinical diagnostic applications require additional wet-lab validation, Sanger sequencing confirmation, and regulatory approval before patient use.

Design CDH1 Primers Now

Pre-configured with CDH1-specific parameters. Use our primer design, Tm calculator, and GC content tools for optimal results.

Design CDH1 Primers → Tm Calculator GC Calculator